Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shihao Cheng

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Communications Biology|December 5, 2025
Structural mechanisms and insights on multiple nanobodies binding diverse SOD1 epitopesShihao Cheng, Chao Zhong, Haoran Zhu, et al.
European Journal of Medicinal Chemistry|June 22, 2023
Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase BShihao Cheng, Yi Zou, Xi Chen, et al.
Bioorganic & Medicinal Chemistry|September 23, 2022
Discovery of biphenyls bearing thiobarbiturate fragment by structure-based strategy as Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitorsShihao Cheng, Qinglin Wang, Xi Chen, et al.
Journal of Medicinal Chemistry|May 6, 2026
Rhodanine-Inspired Development of Dual-Action <i>Mycobacterium tuberculosis</i> Protein Tyrosine Phosphatase B InhibitorsHaofan Shao, Xiaoyu Wu, Shihao Cheng, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Communications Biology|December 5, 2025
Structural mechanisms and insights on multiple nanobodies binding diverse SOD1 epitopesShihao Cheng, Chao Zhong, Haoran Zhu, et al.
European Journal of Medicinal Chemistry|June 22, 2023
Design, synthesis and biological evaluation of 3-substituted-2-thioxothiazolidin-4-one (rhodanine) derivatives as antitubercular agents against Mycobacterium tuberculosis protein tyrosine phosphatase BShihao Cheng, Yi Zou, Xi Chen, et al.
Bioorganic & Medicinal Chemistry|September 23, 2022
Discovery of biphenyls bearing thiobarbiturate fragment by structure-based strategy as Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitorsShihao Cheng, Qinglin Wang, Xi Chen, et al.
Journal of Medicinal Chemistry|May 6, 2026
Rhodanine-Inspired Development of Dual-Action <i>Mycobacterium tuberculosis</i> Protein Tyrosine Phosphatase B InhibitorsHaofan Shao, Xiaoyu Wu, Shihao Cheng, et al.
Pageof 3